Bolt Biotherapeutics, Inc. — Director's Dealing 2021

Dec 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bolt Biotherapeutics, Inc. (BOLT)
CIK: 0001641281
Period of Report: 2021-12-08

Reporting Person: Quinn William P. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-04	Common Stock	P	1221	$16.65	Acquired	15119	Direct
2021-12-06	Common Stock	P	35	$4.64	Acquired	15154	Direct
2021-12-08	Common Stock	P	5000	$4.715	Acquired	20154	Direct

Footnotes

F1: Shares acquired under the issuer's Employee Stock Purchase Plan.